Unknown

Dataset Information

CRISPR/Cas9-Mediated Correction of the FANCD1 Gene in Primary Patient Cells.


ABSTRACT: Fanconi anemia (FA) is an inherited condition characterized by impaired DNA repair, physical anomalies, bone marrow failure, and increased incidence of malignancy. Gene editing holds great potential to precisely correct the underlying genetic cause such that gene expression remains under the endogenous control mechanisms. This has been accomplished to date only in transformed cells or their reprogrammed induced pluripotent stem cell counterparts; however, it has not yet been reported in primary patient cells. Here we show the ability to correct a mutation in Fanconi anemia D1 (FANCD1) primary patient fibroblasts. The clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 system was employed to target and correct a FANCD1 gene deletion. Homologous recombinatio

SUBMITTER: Skvarova Kramarzova K 

PROVIDER: S-EPMC5486091 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature